Category Archives: Myocardial Infarction

Verily, a San Francisco-based subsidiary of Alphabet focused on life sciences and healthcare, announced partnerships with the Veterans Administration Palo Alto Healthcare System (VAPAHCS) and Atrius Health to evaluate and deploy new tools and interventions aimed at optimizing care delivery. The partnerships leverage Verilys experience in data ingestion, analytics, behavioral activation, and product development to improve the value of care Continue reading →

1. After adjustment for established cardiovascular risk factors, the diagnosis of non-alcoholic fatty liver disease (NAFLD)does not appear to be associated with risk of acute myocardial infarction or stroke Continue reading →

Background and Purpose More intensive secondary prevention with newer drugs may be cost-effective in patients withcoronary artery disease(CAD). Continue reading →

People who take all of their blood-pressure medication in one go at bedtime are better able to control their condition and have a significantly lower risk of death or illness caused by heart or blood vessel problems compared to those who take their anti-hypertensive medication in the morning, according to research published this month in the peer-reviewed European Heart Journal. Continue reading →

Cardiac Biomarkers Testing Market by Type (Myocardial Muscle Creatine Kinase, Troponins, Myoglobin, Brain Natriuretic Peptide, Ischemia-modified Albumin, and Others), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others) and Location of Testing (Point of care Testing and Laboratory Testing): Global Opportunity Analysis and Industry Forecast, 20192026 New York, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Biomarkers Testing Market by Type, Application and Location of Testing: Global Opportunity Analysis and Industry Forecast, 20192026" - https://www.reportlinker.com/p05793200/?utm_source=GNW The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4% Continue reading →

Myocardial Infarction Drug market research report provides the details about Industry Chain structure, Market Competition, Market Size & Share, SWOT Analysis, Technology, Cost, Raw Materials, Consumer Preference, Development & Trends, Regional Forecast, Company & Profile and Product & Service. Myocardial Infarction Drug market research report also gives information on the Trade Overview, Policy, Regional Market, Production Development, Sales, Regional Trade, Business Operation Data, Market Features, Investment Opportunity, Investment Calculation and other important aspect of the industry. (Halloween Special Discount Offer for Limited Period)Add this report toCART and Use Coupon Code HALLOWEEN40 to avail 40% Instant Discounthttps://inforgrowth.com/report/5609003/myocardial-infarction-drug-market The main objectives of the research report elaborate the overall market overview on Myocardial Infarction Drug market dynamics, historic volume and value, robust market methodology, current & future trends, Porters Five Forces Analysis, upstream and downstream industry chain, new technological development, cost structure, government policies & regulations, etc Continue reading →

October 30, 2019 People with high blood pressure who take all their anti-hypertensive medication in one go at bedtime have better controlled blood pressure and a significantly lower risk of death or illness caused by heart or blood vessel problems, compared to those who take their medication in the morning, according to new research. Continue reading →

How good is artificial intelligence in decision-making? Not bad according to findings from a pilot study that was recently presented at the American College of Surgeons Clinical Congress 2019. Continue reading →

Editors note: The opinions expressed by the author do not necessarily reflect the opinions of the AAMC or its members. Recent statistics on electronic nicotine delivery systems (ENDS), popularly known as vaping devices or e-cigarettes, are frightening. The most recent data from the U.S. Continue reading →

October 25, 2019 -In a damning report, researchers determined data breach remediation efforts were linked to decreased patient care outcomes and negatively impacted the timeliness of care. Whats more, ransomware may have a greater short-term negative relationship with patient outcomes. Published by Health Services Research, University of Central Florida and Vanderbilt University researchers Sung Choi, M. Continue reading →